AstraZeneca Pharma India inaugurated a corporate office in Mumbai, strengthening its presence in India and supporting its ambition to transform healthcare through scientific innovation. The move reinforces the company’s commitment to advancing medical research, improving access to innovative treatments and collaborating with India’s healthcare ecosystem. Spread across 25,600 sq ft, the office was inaugurated by Devendra Fadnavis, Chief Minister of Maharashtra, alongside senior government officials, diplomatic representatives and members of the AstraZeneca team.
AstraZeneca Strengthens Healthcare Innovation in India
The Mumbai office marks an important step in AstraZeneca’s growth strategy in India. By strengthening its presence in the country’s commercial and healthcare ecosystem, the company aims to accelerate collaboration, support scientific advancement and improve patient access to innovative medicines. Over the past three years, AstraZeneca has introduced more than 25 new medicines and indications in India. In addition, the company is conducting approximately 80 global clinical trials in the country, strengthening India’s contribution to international medical research and the development of new treatments. These initiatives reflect AstraZeneca’s focus on advancing scientific discoveries and helping deliver the right medicines to the right patients more quickly. The company’s expanded presence could also strengthen collaboration between pharmaceutical businesses, healthcare institutions and other stakeholders across the region.
Focus on Patient Access and Innovative Treatments
Praveen Rao Akkinepally, Country President and Managing Director of AstraZeneca Pharma India, said India was at an important stage in healthcare development, with increasing demand for earlier diagnosis, innovative treatments and more equitable access to healthcare. He explained that the stronger presence in Mumbai would help AstraZeneca work more closely with partners across the healthcare ecosystem and develop solutions that address the needs of patients in India.
Investment in Talent and Capability Development
The new office will also support AstraZeneca’s continued investment in talent development and organisational capabilities in India. As the company expands its operations, it plans to create opportunities for professionals working across healthcare, science, technology and related functions. Furthermore, AstraZeneca aims to attract and develop diverse talent across its value chain, strengthening the skills and capabilities required to support future innovation.
AstraZeneca Advances Its Healthcare Mission
AstraZeneca’s stronger footprint in Mumbai forms part of its broader global mission to advance equitable healthcare through science and innovation. As reported by biospectrumindia.com, by combining its growing presence in India with continued clinical research, talent development and collaboration across the healthcare ecosystem, the company aims to contribute to medical innovation and improve access to advanced treatments for patients.
